Sialic Acid-Mimic Peptides As Hemagglutinin Inhibitors for Anti-Influenza Therapy
- 18 May 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 53 (11), 4441-4449
- https://doi.org/10.1021/jm1002183
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutantsNature, 2008
- Oseltamivir (Tamiflu®) and its potential for use in the event of an influenza pandemicJournal of Antimicrobial Chemotherapy, 2005
- Sialobiology of Influenza: Molecular Mechanism of Host Range Variation of Influenza VirusesBiological & Pharmaceutical Bulletin, 2005
- Natural and synthetic sialic acid‐containing inhibitors of influenza virus receptor bindingReviews in Medical Virology, 2003
- Realities and enigmas of human viral influenza: pathogenesis, epidemiology and controlVaccine, 2002
- An O-glycoside of sialic acid derivative that inhibits both hemagglutinin and sialidase activities of influenza virusesGlycobiology, 2002
- Influenza chemotherapy: a review of the present state of art and of new drugs in development.Archiv für die gesamte Virusforschung, 2000
- A novel approach to antiviral therapy for influenza.Journal of Antimicrobial Chemotherapy, 1999
- Rational design of potent sialidase-based inhibitors of influenza virus replicationNature, 1993
- THE STRUCTURE AND FUNCTION OF THE HEMAGGLUTININ MEMBRANE GLYCOPROTEIN OF INFLUENZA VIRUSAnnual Review of Biochemistry, 1987